CRP and systemic sclerosis: Risk stratification of SSc patients by ASCVD risk into a low-ASCVD SSc risk group (<5% ASCVD 10-year risk) and into a combined intermediate-to-high risk ASCVD risk group (IMH risk group, ≥7.5% or > 20% 10y-ASCVD risk estimated) confirmed significantly higher CRP levels in the IMH-risk SSc group compared to low-risk SSc individuals (p = 0.024) (Supplementary Table 1).